Results 131 to 140 of about 47,911 (266)
Introducing azobenzenes as solid phase peptide synthesis linkers. [PDF]
Śmieja CB +5 more
europepmc +1 more source
HARNESSING THE HUMAN RESOURCES IN AMC [PDF]
openaire +2 more sources
Background Primary orthostatic tremor (POT) is a rare hyperkinetic movement disorder with limited and largely ineffective treatment options. Perampanel has been suggested as a therapy, but has so far only been investigated in small studies with short duration.
Wietske A. Babeliowsky +4 more
wiley +1 more source
A novel biosensor for measuring plasmin activity. [PDF]
Dai Y +4 more
europepmc +1 more source
Abstract Background Deep brain stimulation (DBS) of the subthalamic nucleus (STN) is an established treatment for Parkinson's disease (PD). Using 7‐Tesla (7 T) MRI connectivity analysis to visualize the patient‐specific STN motor subdivision, we hypothesize that reprogramming patients who are stimulated outside of this subdivision can improve their ...
Yarit Wiggerts +6 more
wiley +1 more source
Embodied language and early motor restriction: evidence from children with obstetric brachial plexus palsy and arthrogryposis. [PDF]
Kadieva D +4 more
europepmc +1 more source
AMC Construction LLC is a veteran-owned residential construction company based in Columbia, Tennessee. Founded in 2013, this firm has grown from a passionate local builder to a trusted name in custom home construction across Middle Tennessee. 🎖️ Built on military values like integrity, discipline, and attention to detail, the team at AMC brings those ...
openaire +2 more sources
Information Design for Early‐Stage Dose‐Finding Trials
ABSTRACT To enhance enrollment rates in early‐stage dose‐finding clinical trials, we propose an information design approach, where the clinical investigator (CI) commits to an information releasing mechanism (IRM) based on the treatment's uncertain efficacy and toxicity to encourage patients to participate in the trial.
Amin Khademi, Ningyuan Chen
wiley +1 more source
Cell-dependent antithrombotic effect of tranexamic acid. [PDF]
Balog Virág K +8 more
europepmc +1 more source

